4 months ago
LLY
AnalystsChris SchottChris Schott's Stock Forecasts
AnalystsChris Schott
Analyst Ranking
Top 17%
#860 out of 5279 analysts
Average Return
+7.76%
Win Rate
59%54 out of 91
Risk vs Reward
Poor
Good
Chris Schott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Teva Pharmaceutical Industries LtdTEVA | +99.55% | $17.96 | $35.84 | 2025-05-11 - 2026-05-11 | Strong Buy |
Eli Lilly & CoLLY | +85.30% | $395.86 | $733.51 | 2023-04-27 - 2024-04-26 | Strong Buy |
Eli Lilly & CoLLY | +75.50% | $458.48 | $804.62 | 2023-07-27 - 2024-07-26 | Strong Buy |
Amneal Pharmaceuticals IncAMRX | +73.73% | $8.30 | $14.42 | 2025-02-23 - 2026-02-23 | Strong Buy |
Kala Bio IncKALA | +73.24% | $10,275.00 | $17,800.00 | 2019-11-07 - 2020-11-06 | Strong Buy |
Chris Schott Analyst Color
Get additional color on Chris Schott's coverage of popular stocks
5 months ago
TEVA
6 months ago
LLY
7 months ago
TEVA
7 months ago
ABBV
7 months ago
GILD
8 months ago
TEVA
8 months ago
GILD
8 months ago
LLY
8 months ago
AMRX
8 months ago
ABBV
9 months ago
LLY
10 months ago
IDXX
a year ago
TEVA
a year ago
AMRX
2 years ago
LLY
2 years ago
LLY
2 years ago
LLY
3 years ago
PFE
3 years ago
LLY
3 years ago
LLY
3 years ago
LLY
3 years ago
LLY
Chris Schott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $850.00 | +32.28% | Maintains | 4 days ago |
Zoetis IncZTS | 4 | Strong Buy | $130.00 | +62.36% | Maintains | 14 days ago |
Viatris IncVTRS | 3 | Hold | $18.00 | +9.36% | Maintains | 14 days ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $58.00 | +8.31% | Maintains | 15 days ago |
Elanco Animal Health IncELAN | 6 | Strong Buy | $30.00 | +40.71% | Maintains | 15 days ago |
Teva Pharmaceutical Industries LtdTEVA | 11 | Strong Buy | $40.00 | +17.10% | Maintains | 21 days ago |
Merck & Co IncMRK | 5 | Strong Buy | $135.00 | +16.50% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 1 | Hold | $250.00 | +7.88% | Maintains | 3 months ago |
Eli Lilly & CoLLY | 16 | Strong Buy | $1,300.00 | +24.80% | Maintains | 4 months ago |
Perrigo Co PLCPRGO | 7 | Hold | $18.00 | +58.59% | Maintains | 5 months ago |
Organon & CoOGN | 3 | Strong Sell | $12.00 | -10.58% | Maintains | 6 months ago |
Idexx Laboratories IncIDXX | 9 | Strong Buy | $775.00 | +40.13% | Maintains | 7 months ago |
Abbvie IncABBV | 4 | Strong Buy | $260.00 | +21.21% | Maintains | 7 months ago |
Gilead Sciences IncGILD | 8 | Strong Buy | $150.00 | +14.94% | Maintains | 7 months ago |
Amneal Pharmaceuticals IncAMRX | 3 | Strong Buy | $14.00 | +12.72% | Maintains | 8 months ago |
Biogen IncBIIB | 4 | Hold | $175.00 | N/A | Maintains | a year ago |
Amgen IncAMGN | 1 | Hold | $270.00 | N/A | Reinstates | 3 years ago |
Pfizer IncPFE | 3 | Hold | $34.00 | N/A | Maintains | 3 years ago |
Coherus Oncology IncCHRS | 2 | Hold | $11.00 | N/A | Maintains | 4 years ago |
Eqrx IncEQRX | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Heska CorpHSKA | 2 | Strong Buy | $150.00 | N/A | Maintains | 4 years ago |
Bausch Health Companies IncBHC | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Strong Buy | $110.00 | N/A | Initiates Coverage On | 6 years ago |
Kala Bio IncKALA | 4 | Strong Buy | $47,500.00 | N/A | Maintains | 6 years ago |
Endo International PLCENDPQ | 2 | Hold | $10.00 | N/A | Maintains | 7 years ago |
Pacira Biosciences IncPCRX | 2 | Hold | $50.00 | N/A | Maintains | 8 years ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $74.00 | N/A | Maintains | 8 years ago |
Therapeuticsmd IncTXMD | 1 | Strong Buy | $550.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.